Coagulation Testing Market By Product (Instruments, Consumables), By Application (Prothrombin Time, Activated Partial Thromboplastin Time, Thrombin Time, Activated Clotting Time), By End User (Hospitals, Clinical Laboratories, Point-of-Care Testing, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Coagulation Testing Market

Coagulation testing is a type of blood test that evaluates a patient's blood's clotting capacity and clotting time. Clotting problems can result in excessive bleeding or clotting, both of which can be fatal. If the doctor thinks the patient has clotting issues, coagulation testing is prescribed. There are several inherited and acquired bleeding disorders, the most prevalent of which include haemophilia, blood factor deficiencies, and others. It is crucial to recognize bleeding disorders and keep a watch on the coagulation status since they can lead to abnormal bleeding. The global market for coagulation testing is growing significantly as a result of surge in prevalence of blood clotting issues in many regions and the rise in cardiovascular illnesses, which can also call for routine coagulation testing. These two factors are driving up the demand for coagulation testing market growth.

Point-of-care (POC) devices are created using highly sophisticated technologies like photoacoustic detection and fluorescence microscopy that are both affordable and extremely reliable. Chronic blood disorders and significantly rising cardiovascular issues are predicted to drive the expansion of the global market. For instance, according to research by the World Health Organization (WHO), around 31% of all patient fatalities each year are caused by cardiovascular disorders (CVDs). The excessive pricing of these devices is expected to slow down coagulation testing market. Furthermore, the coagulation testing market's growth is being constrained by stringent rules for testing device authorization. In the near future, there will be profitable growth prospects due to the increasing need for disposable coagulation testing equipment. The market for coagulation testing is growing significantly as a result of distribution channels. The kit is conveniently offered at local drug stores. New e-commerce platforms are increasing the product's visibility in the meantime. In 2018, Sysmex launched the Automated Blood Coagulation Analyzers CN-6000 and CN-3000.

The global coagulation testing market share is segmented based on, product type, application, end-use industry, and region. By product type, it is classified into Instruments, and consumables. By application it is classified into prothrombin time, activated partial thromboplastin time, thrombin time, and activated clotting time. By end-use industry, it is classified into hospitals, clinical laboratories, point-of-care testing, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in the coagulation testing market report include Thermo Fisher Scientific Inc., Helena Laboratories Corporation., Micropoint Biosciences, Medtronic, F. Hoffmann-La Roche Ltd, nihon kohden corporation., Abbott., Sysmex Corporation, BD., Danaher.

The report offers a comprehensive analysis of the global coagulation testing market trends by thoroughly studying different aspects of the market, including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working toward the growth of the market. Furthermore, report sheds light on the present scenario and upcoming trends & developments that are contributing to the growth of the market. Moreover, restraints and challenges that hold power to obstruct the market growth are profiled in the report along with the Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and emergence of substitutes in the market.

Impact of Covid-19 on the Global Coagulation Testing Industry

The coagulation testing market is anticipated to experience potential growth owing to increase in awareness among the population, the benefits of early diagnosis, and potential application in the monitoring of blood flow in COVID-19 affected patients.

The COVID-19 pandemic has positively affected the global coagulation testing market. Many scientists are focusing on identifying the coagulopathy behavior linked to the novel coronavirus.

The coagulation testing market is expected to experience a potential growth, owing to increasing awareness among the people, the benefits of early diagnosis, and potential application in the monitoring of blood flow in COVID-19 affected patients.

Key Findings of the Study

Based on product type, the consumable sub-segment emerged as the global leader in 2018, while the instruments sub-segment is anticipated to be the fastest growing sub-segment during the forecast period.

Based on application, the prothrombin time sub-segment emerged as the global leader in 2018 during the forecast period.

Based on end-use industry, the hospital sub-segment emerged as the global leader in 2021, and point-of-care testing sub-segment is predicted to show the fastest growth in the upcoming years.

Based on region, Europe market registered the highest market share in 2021 and Asia-Pacific is projected to be the fastest growing market during the forecast period.

Overview

The global coagulation testing market size is envisioned to garner $8,777.3 million by 2031, growing from $3,101.7 million in 2021 at a CAGR of 11.5% from 2022 to 2031.

Medical professionals use coagulation tests to evaluate the hemostasis system. A coagulometer, which monitors and assesses the rate of clot formation or blood coagulation, is mostly used to conduct this test. These examinations reduce the risk of heart attack, thrombosis, and embolism by detecting the presence of blood clots in blood arteries.

Hemostasis (coagulation), a complicated process that regulates blood flow and clot formation, is controlled by numerous enzymes and proteins.

The market is expanding as a result of ongoing technological developments in coagulation testing equipment. The key growth reasons for the coagulation testing market are the rising prevalence of different blood clotting disorders, including deep vein thrombosis (DVT) and haemophilia, as well as the global ageing population. The market is comprehensively evaluated in the study on the global coagulation testing market growth.

Due to stringent government regulations along with high risk and costs associated with tests and treatment which limits its usage to only the population which is economically capable gives a negative impact on the global coagulation testing markets.

In the self-testing technology, the smartphone-based blood coagulation testing device which is driving the growth of the market helps to monitors the blood flow in patients by undergoing an anticoagulant therapy. These factors drives the coagulation testing market demand.

The COVID-19 pandemic brought about a number of difficulties that resulted in significant economic losses as a result of the global shutdown of many firms. There were established import-export limitations. The COVID-19 pandemic has had a beneficial impact on the market for coagulation testing worldwide. Numerous government agencies are taking a number of actions to help businesses survive the coronavirus epidemic. Many government agencies are taking a number of actions to help businesses survive the coronavirus outbreak.

The key players profiled in this report include Thermo Fisher Scientific Inc., Helena Laboratories Corporation., Micropoint Biosciences, Medtronic, F. Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION., Abbott., Sysmex Corporation, BD Biosciences., and Danaher.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coagulation testing market analysis from 2021 to 2031 to identify the prevailing coagulation testing market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the coagulation testing market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global coagulation testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Micropoint Bioscience

Scope of Coagulation Testing Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

3.7.Value Chain Analysis

3.8.Market Share Analysis

3.9.Regulatory Guidelines

3.10.Key Regulation Analysis

3.11.Patent Landscape

4.1 Overview

4.1.1 Market size and forecast

4.2 Instruments

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Consumables

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Prothrombin Time

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Activated Partial Thromboplastin Time

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Thrombin Time

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

5.5 Activated Clotting Time

5.5.1 Key market trends, growth factors and opportunities

5.5.2 Market size and forecast, by region

5.5.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Hospitals

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Clinical Laboratories

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

6.4 Point-of-Care Testing

6.4.1 Key market trends, growth factors and opportunities

6.4.2 Market size and forecast, by region

6.4.3 Market analysis by country

6.5 Others

6.5.1 Key market trends, growth factors and opportunities

6.5.2 Market size and forecast, by region

6.5.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by Product

7.2.3 North America Market size and forecast, by Application

7.2.4 North America Market size and forecast, by End User

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Market size and forecast, by Product

7.2.5.1.2 Market size and forecast, by Application

7.2.5.1.3 Market size and forecast, by End User

7.2.5.2 Canada

7.2.5.2.1 Market size and forecast, by Product

7.2.5.2.2 Market size and forecast, by Application

7.2.5.2.3 Market size and forecast, by End User

7.2.5.3 Mexico

7.2.5.3.1 Market size and forecast, by Product

7.2.5.3.2 Market size and forecast, by Application

7.2.5.3.3 Market size and forecast, by End User

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by Product

7.3.3 Europe Market size and forecast, by Application

7.3.4 Europe Market size and forecast, by End User

7.3.5 Europe Market size and forecast, by country

7.3.5.1 Germany

7.3.5.1.1 Market size and forecast, by Product

7.3.5.1.2 Market size and forecast, by Application

7.3.5.1.3 Market size and forecast, by End User

7.3.5.2 United Kingdom

7.3.5.2.1 Market size and forecast, by Product

7.3.5.2.2 Market size and forecast, by Application

7.3.5.2.3 Market size and forecast, by End User

7.3.5.3 France

7.3.5.3.1 Market size and forecast, by Product

7.3.5.3.2 Market size and forecast, by Application

7.3.5.3.3 Market size and forecast, by End User

7.3.5.4 Spain

7.3.5.4.1 Market size and forecast, by Product

7.3.5.4.2 Market size and forecast, by Application

7.3.5.4.3 Market size and forecast, by End User

7.3.5.5 Italy

7.3.5.5.1 Market size and forecast, by Product

7.3.5.5.2 Market size and forecast, by Application

7.3.5.5.3 Market size and forecast, by End User

7.3.5.6 Rest of Europe

7.3.5.6.1 Market size and forecast, by Product

7.3.5.6.2 Market size and forecast, by Application

7.3.5.6.3 Market size and forecast, by End User

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by Product

7.4.3 Asia-Pacific Market size and forecast, by Application

7.4.4 Asia-Pacific Market size and forecast, by End User

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 China

7.4.5.1.1 Market size and forecast, by Product

7.4.5.1.2 Market size and forecast, by Application

7.4.5.1.3 Market size and forecast, by End User

7.4.5.2 Japan

7.4.5.2.1 Market size and forecast, by Product

7.4.5.2.2 Market size and forecast, by Application

7.4.5.2.3 Market size and forecast, by End User

7.4.5.3 India

7.4.5.3.1 Market size and forecast, by Product

7.4.5.3.2 Market size and forecast, by Application

7.4.5.3.3 Market size and forecast, by End User

7.4.5.4 South Korea

7.4.5.4.1 Market size and forecast, by Product

7.4.5.4.2 Market size and forecast, by Application

7.4.5.4.3 Market size and forecast, by End User

7.4.5.5 Australia

7.4.5.5.1 Market size and forecast, by Product

7.4.5.5.2 Market size and forecast, by Application

7.4.5.5.3 Market size and forecast, by End User

7.4.5.6 Rest Of Asia Pacific

7.4.5.6.1 Market size and forecast, by Product

7.4.5.6.2 Market size and forecast, by Application

7.4.5.6.3 Market size and forecast, by End User

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by Product

7.5.3 LAMEA Market size and forecast, by Application

7.5.4 LAMEA Market size and forecast, by End User

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Brazil

7.5.5.1.1 Market size and forecast, by Product

7.5.5.1.2 Market size and forecast, by Application

7.5.5.1.3 Market size and forecast, by End User

7.5.5.2 Saudi Arabia

7.5.5.2.1 Market size and forecast, by Product

7.5.5.2.2 Market size and forecast, by Application

7.5.5.2.3 Market size and forecast, by End User

7.5.5.3 UAE

7.5.5.3.1 Market size and forecast, by Product

7.5.5.3.2 Market size and forecast, by Application

7.5.5.3.3 Market size and forecast, by End User

7.5.5.4 South Africa

7.5.5.4.1 Market size and forecast, by Product

7.5.5.4.2 Market size and forecast, by Application

7.5.5.4.3 Market size and forecast, by End User

7.5.5.5 Rest of LAMEA

7.5.5.5.1 Market size and forecast, by Product

7.5.5.5.2 Market size and forecast, by Application

7.5.5.5.3 Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 Alere Inc.

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 Nihon Kohden Corporation

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 F. Hoffmann-La Roche Ltd.

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 Sysmex Corporation

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 Thermo Fisher Scientific Inc.

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 Diagnostica Stago Sas

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 Helena Laboratories

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 Abbott Laboratories

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 Medtronic plc

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 Micropoint Biosciences

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 2. COAGULATION TESTING MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)

TABLE 3. COAGULATION TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 4. COAGULATION TESTING MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)

TABLE 5. COAGULATION TESTING MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 6. GLOBAL COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 7. COAGULATION TESTING MARKET SIZE, FOR PROTHROMBIN TIME, BY REGION, 2021-2031 ($MILLION)

TABLE 8. COAGULATION TESTING MARKET FOR PROTHROMBIN TIME, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 9. COAGULATION TESTING MARKET SIZE, FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2021-2031 ($MILLION)

TABLE 10. COAGULATION TESTING MARKET FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 11. COAGULATION TESTING MARKET SIZE, FOR THROMBIN TIME, BY REGION, 2021-2031 ($MILLION)

TABLE 12. COAGULATION TESTING MARKET FOR THROMBIN TIME, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 13. COAGULATION TESTING MARKET SIZE, FOR ACTIVATED CLOTTING TIME, BY REGION, 2021-2031 ($MILLION)

TABLE 14. COAGULATION TESTING MARKET FOR ACTIVATED CLOTTING TIME, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 15. GLOBAL COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 16. COAGULATION TESTING MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 17. COAGULATION TESTING MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 18. COAGULATION TESTING MARKET SIZE, FOR CLINICAL LABORATORIES, BY REGION, 2021-2031 ($MILLION)

TABLE 19. COAGULATION TESTING MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 20. COAGULATION TESTING MARKET SIZE, FOR POINT-OF-CARE TESTING, BY REGION, 2021-2031 ($MILLION)

TABLE 21. COAGULATION TESTING MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 22. COAGULATION TESTING MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 23. COAGULATION TESTING MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 24. COAGULATION TESTING MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 25. NORTH AMERICA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 26. NORTH AMERICA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 27. NORTH AMERICA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 28. NORTH AMERICA COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 29. U.S. COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 30. U.S. COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 31. U.S. COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 32. CANADA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 33. CANADA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 34. CANADA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 35. MEXICO COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 36. MEXICO COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 37. MEXICO COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 38. EUROPE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 39. EUROPE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 40. EUROPE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 41. EUROPE COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 42. GERMANY COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 43. GERMANY COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 44. GERMANY COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 45. UNITED KINGDOM COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 46. UNITED KINGDOM COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 47. UNITED KINGDOM COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 48. FRANCE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 49. FRANCE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 50. FRANCE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 51. SPAIN COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 52. SPAIN COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 53. SPAIN COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 54. ITALY COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 55. ITALY COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 56. ITALY COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 57. REST OF EUROPE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 58. REST OF EUROPE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 59. REST OF EUROPE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 60. ASIA-PACIFIC COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 61. ASIA-PACIFIC COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 62. ASIA-PACIFIC COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 63. ASIA-PACIFIC COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 64. CHINA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 65. CHINA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 66. CHINA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 67. JAPAN COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 68. JAPAN COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 69. JAPAN COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 70. INDIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 71. INDIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 72. INDIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 73. SOUTH KOREA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 74. SOUTH KOREA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 75. SOUTH KOREA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 76. AUSTRALIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 77. AUSTRALIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 78. AUSTRALIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 79. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 80. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 81. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 82. LAMEA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 83. LAMEA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 84. LAMEA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 85. LAMEA COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 86. BRAZIL COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 87. BRAZIL COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 88. BRAZIL COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 89. SAUDI ARABIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 90. SAUDI ARABIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 91. SAUDI ARABIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 92. UAE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 93. UAE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 94. UAE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 95. SOUTH AFRICA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 96. SOUTH AFRICA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 97. SOUTH AFRICA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 98. REST OF LAMEA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 99. REST OF LAMEA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 100. REST OF LAMEA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 101.ALERE INC.: COMPANY SNAPSHOT

TABLE 102.ALERE INC.: OPERATING SEGMENTS

TABLE 103.ALERE INC.: PRODUCT PORTFOLIO

TABLE 104.ALERE INC.: NET SALES,

TABLE 105.ALERE INC.: KEY STRATERGIES

TABLE 106.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

TABLE 107.NIHON KOHDEN CORPORATION: OPERATING SEGMENTS

TABLE 108.NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO

TABLE 109.NIHON KOHDEN CORPORATION: NET SALES,

TABLE 110.NIHON KOHDEN CORPORATION: KEY STRATERGIES

TABLE 111.F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT

TABLE 112.F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS

TABLE 113.F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO

TABLE 114.F. HOFFMANN-LA ROCHE LTD.: NET SALES,

TABLE 115.F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES

TABLE 116.SYSMEX CORPORATION: COMPANY SNAPSHOT

TABLE 117.SYSMEX CORPORATION: OPERATING SEGMENTS

TABLE 118.SYSMEX CORPORATION: PRODUCT PORTFOLIO

TABLE 119.SYSMEX CORPORATION: NET SALES,

TABLE 120.SYSMEX CORPORATION: KEY STRATERGIES

TABLE 121.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT

TABLE 122.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS

TABLE 123.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO

TABLE 124.THERMO FISHER SCIENTIFIC INC.: NET SALES,

TABLE 125.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES

TABLE 126.DIAGNOSTICA STAGO SAS: COMPANY SNAPSHOT

TABLE 127.DIAGNOSTICA STAGO SAS: OPERATING SEGMENTS

TABLE 128.DIAGNOSTICA STAGO SAS: PRODUCT PORTFOLIO

TABLE 129.DIAGNOSTICA STAGO SAS: NET SALES,

TABLE 130.DIAGNOSTICA STAGO SAS: KEY STRATERGIES

TABLE 131.HELENA LABORATORIES: COMPANY SNAPSHOT

TABLE 132.HELENA LABORATORIES: OPERATING SEGMENTS

TABLE 133.HELENA LABORATORIES: PRODUCT PORTFOLIO

TABLE 134.HELENA LABORATORIES: NET SALES,

TABLE 135.HELENA LABORATORIES: KEY STRATERGIES

TABLE 136.ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 137.ABBOTT LABORATORIES: OPERATING SEGMENTS

TABLE 138.ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 139.ABBOTT LABORATORIES: NET SALES,

TABLE 140.ABBOTT LABORATORIES: KEY STRATERGIES

TABLE 141.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 142.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 143.MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 144.MEDTRONIC PLC: NET SALES,

TABLE 145.MEDTRONIC PLC: KEY STRATERGIES

TABLE 146.MICROPOINT BIOSCIENCES: COMPANY SNAPSHOT

TABLE 147.MICROPOINT BIOSCIENCES: OPERATING SEGMENTS

TABLE 148.MICROPOINT BIOSCIENCES: PRODUCT PORTFOLIO

TABLE 149.MICROPOINT BIOSCIENCES: NET SALES,

TABLE 150.MICROPOINT BIOSCIENCES: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.COAGULATION TESTING MARKET SEGMENTATION

FIGURE 2.COAGULATION TESTING MARKET,2021-2031

FIGURE 3.COAGULATION TESTING MARKET,2021-2031

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.COAGULATION TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.VALUE CHAIN ANALYSIS

FIGURE 13.MARKET SHARE ANALYSIS

FIGURE 14.REGULATORY GUIDELINES

FIGURE 15.KEY REGULATION ANALYSIS

FIGURE 16.PATENT ANALYSIS BY COMPANY

FIGURE 17.PATENT ANALYSIS BY COUNTRY

FIGURE 18.COAGULATION TESTING MARKET,BY PRODUCT,2021(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS COAGULATION TESTING MARKET,2021-2031(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES COAGULATION TESTING MARKET,2021-2031(%)

FIGURE 21.COAGULATION TESTING MARKET,BY APPLICATION,2021(%)

FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PROTHROMBIN TIME COAGULATION TESTING MARKET,2021-2031(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ACTIVATED PARTIAL THROMBOPLASTIN TIME COAGULATION TESTING MARKET,2021-2031(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF THROMBIN TIME COAGULATION TESTING MARKET,2021-2031(%)

FIGURE 25.COMPARATIVE SHARE ANALYSIS OF ACTIVATED CLOTTING TIME COAGULATION TESTING MARKET,2021-2031(%)

FIGURE 26.COAGULATION TESTING MARKET,BY END USER,2021(%)

FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HOSPITALS COAGULATION TESTING MARKET,2021-2031(%)

FIGURE 28.COMPARATIVE SHARE ANALYSIS OF CLINICAL LABORATORIES COAGULATION TESTING MARKET,2021-2031(%)

FIGURE 29.COMPARATIVE SHARE ANALYSIS OF POINT-OF-CARE TESTING COAGULATION TESTING MARKET,2021-2031(%)

FIGURE 30.COMPARATIVE SHARE ANALYSIS OF OTHERS COAGULATION TESTING MARKET,2021-2031(%)

FIGURE 31.COAGULATION TESTING MARKET BY REGION,2021

FIGURE 32.U.S. COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 33.CANADA COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 34.MEXICO COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 35.GERMANY COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 36.UNITED KINGDOM COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 37.FRANCE COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 38.SPAIN COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 39.ITALY COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 40.REST OF EUROPE COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 41.CHINA COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 42.JAPAN COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 43.INDIA COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 44.SOUTH KOREA COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 45.AUSTRALIA COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 46.REST OF ASIA PACIFIC COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 47.BRAZIL COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 48.SAUDI ARABIA COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 49.UAE COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 50.SOUTH AFRICA COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 51.REST OF LAMEA COAGULATION TESTING MARKET,2021-2031($MILLION)

FIGURE 52. TOP WINNING STRATEGIES, BY YEAR

FIGURE 53. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 54. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 55.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 56.COMPETITIVE DASHBOARD

FIGURE 57.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 58.ALERE INC..: NET SALES ,($MILLION)

FIGURE 59.NIHON KOHDEN CORPORATION.: NET SALES ,($MILLION)

FIGURE 60.F. HOFFMANN-LA ROCHE LTD..: NET SALES ,($MILLION)

FIGURE 61.SYSMEX CORPORATION.: NET SALES ,($MILLION)

FIGURE 62.THERMO FISHER SCIENTIFIC INC..: NET SALES ,($MILLION)

FIGURE 63.DIAGNOSTICA STAGO SAS.: NET SALES ,($MILLION)

FIGURE 64.HELENA LABORATORIES.: NET SALES ,($MILLION)

FIGURE 65.ABBOTT LABORATORIES.: NET SALES ,($MILLION)

FIGURE 66.MEDTRONIC PLC.: NET SALES ,($MILLION)

FIGURE 67.MICROPOINT BIOSCIENCES.: NET SALES ,($MILLION